I’m struggling to understand the news flow slides in some of these recent presentations. Are they saying that submitting something to the FDA on time (end of March) is something newsworthy for the ASX. Also is the FDA 2x2 confirmation expected soon? It’s all a bit convoluted and I’ve been a holder since 2018. Still optimistic - just confused at the lack of material activity.
Ann: PAR to present at NWR Healthcare Conference, page-35
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.5¢ |
Change
0.005(2.08%) |
Mkt cap ! $85.73M | |||
| Open | High | Low | Value | Volume |
| 24.0¢ | 25.0¢ | 23.0¢ | $180.4K | 746.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 79748 | 24.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.0¢ | 22818 | 4 |
View Market Depth
| Last trade - 16.10pm 14/11/2024 (20 minute delay) ? |
| PAR (ASX) Chart |